期刊文献+

福莫特罗和ICI118551对大鼠骨髓间充质干细胞来源的成骨样细胞功能的影响 被引量:5

The effects of Formoterol and ICI118551 on rat osteoblast-like cells in vitro induced from marrow-derived mesenchymal stem cells
下载PDF
导出
摘要 目的:研究选择性β2肾上腺素能激动剂福莫特罗(Formoterol)和阻滞剂ICI118551对体外由大鼠骨髓间充质干细胞(MMSC)成骨分化的影响,探讨β2肾上腺素能受体信号对骨代谢的影响。方法:取3周龄雌性SD大鼠,全贴壁筛选法培养MMSC,用条件培养液诱导向成骨细胞分化后分别加入不同浓度Formoterol和ICI118551,检测细胞碱性磷酸酶,骨钙素的分泌水平和细胞增殖率。结果:MMSC成功诱导分化为成骨样细胞,不同浓度(10-5~10-9mmol/L)的Formoterol均可抑制成骨样细胞分泌碱性磷酸酶,骨钙素和细胞增殖。高浓度ICI118551(10-5和10-6mmol/L)抑制成骨样细胞分泌碱性磷酸酶,骨钙素和细胞增殖,低浓度ICI118551(10-8和10-9mmol/L)则可促进成骨样细胞分泌碱性磷酸酶,骨钙素和细胞增殖。结论:β2肾上腺素能受体激动剂可抑制体外成骨样细胞的功能和细胞增殖,而阻滞剂对成骨样细胞功能和增殖的影响与其浓度有关。 Objectlve:To evaluate the effects of Formoterol(β2-adrenergic receptor-specific agonist) and IC1118551(β2-adrenergic receptor-specific antagonist) on rat osteoblast-like cells induced from marrow-derived mesenchymal stem cells (MMSC). Methods: MMSCs by whole bone marrow adherent culture derived from a three-week-old female SD rat are induced to osteoblast-like cells. After different concentrations of Formoterol and IC1118551 are added into the culture medium,thealkali phosphatase and osteocalcin is detected. Results:The alkali phosphatase,osteocalcin and proliferation of cells cultured with all different concentrations(10^-5-10^-9 mmol/L) of Formoterol are obviously low. As to IC1118551, high concentrations (10^-5 and 10^-6 tool/L) can inhibit the expression of the alkali phosphatase,osteocalcin and proliferation of cells while low concentrations (10^-8 and 10^-9 mol/L) can enhance the expression of the alkali phosphatase, osteocalcin and proliferation. Conclusion:The β2-adrenergic receptor-specific agonist can inhibit the activity of rat osteoblast-like cells in vitro while the effects of the β2-adrenergic receptor-specific antagonist are not single, depending on its concentration.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2009年第6期784-789,共6页 Journal of Nanjing Medical University(Natural Sciences)
关键词 Β2肾上腺素能受体激动剂 β2肾上腺素能受体阻滞剂 大鼠骨髓间充质干细胞 碱性磷酸酶 骨钙素 β2-adrenergic receptor-specific agonist β2-adrenergic receptor-specific antagonist rat marrow-derived mesenchymal stem cells alkali phosphatase osteocalcin
  • 相关文献

参考文献15

  • 1Takeda S,Elefteriou F,Levasseur R,et al. Lep tin regulates bone formation via the sympathetic nervous system. [J]. Ce11,2002,111(3):305-317
  • 2Bjurholm A, Kreicbergs A, Schuhzberg M, et al. Neuroendocrine regulation of cyclic AMP formation in osteoblastic cell lines (UMP-106-01,ROS 17/2.8,MC3T3-E1 ,and Saos-2) and primary bone cells [J]. Bone Miner Res, 1992,7(9) : 1011-1019
  • 3Greenfiel EM,Horowitz MC,Lavish SA. Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediateearly gene response induced by cAMP signal transduction [J]. Biol Chem, 1996,271(18) : 10984-10989
  • 4Moore RE,Smith CK,Bailey CS,et al. Characterization of beta-adrenergic receptors on rat and human osteoblastlike cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture. [J]. Bone Miner, 1993,23(3) :301-315
  • 5Arai M, Nagasawa T, Koshihara Y, et al. Effects of beta-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells[J].Biochem Biophys Acta ,2003,1640 (2-3) : 137-142
  • 6Aitken SJ.Landao-Bassonga E,Ralston SH,et al. Beta2-adrenoreceptor ligands regulate osteoclast differentiation in vitro by direct and indirect mechanisms [J]. Arch Biochem Biophys, 2009,482 (1-2) : 69-103
  • 7Elefteriou F,Ahn JD, Takeda S, et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART[J]. Nature,2005,434(7032) :514-520
  • 8Fu L, Patel MS, Bradley A, et al. The molecular clock mediates leptin-regulated bone formation[J]. Ce11,2005,122 (5) :803-815
  • 9Kellenberger S,Muller K,Richener H,et al. Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors.[J]. Bone, 1998,22(5):471-478
  • 10Osman L,Chester AH,Sarathchandra P,et al. Formoterol and isoproterenol induce c-fos gene expression in osteoblast-like cells by activating beta2-adrenergic receptors [J]. Bone, 1998,22(5) :471-478

同被引文献49

  • 1王和鸣,汪宝军,王竹风,钱松涛,高丽萍,陈敏,柯晓红,余庆阳,何斌.福建省中老年人骨密度的流行病学调查[J].中国骨质疏松杂志,2004,10(4):535-537. 被引量:26
  • 2孙冬梅,刘中博,赵岩,宫振伟,李丹,王溪原,曾宪录,刘文广.Runx2参与调控Osterix启动子活性及其基因表达(英文)[J].生物化学与生物物理进展,2006,33(10):957-964. 被引量:21
  • 3Parikka V, Peng Z, Hentunen T,et al. Estrogen responsiveness of bone formation in vitro and altered bone phenotype in aged estrogen receptor-alpha-deficient male and female mice [J]. Eur J Endocrinol,2005,152(2) :301-314.
  • 4Takeda S, Elefteriou F, Levasseur R, et al. Leptin regulates bone formation via the sympathetic nervous system[J]. Cell. 2002,111(3):305-317.
  • 5Waters KM, Riekard DJ.Riggs BL, et al. Estrogen regulation of human osteoblast function is determined by the stage of differentiation and the estrogen receptor isoform[J]. Cell Biochem,2001, 83(3) :448-462.
  • 6Bonnet N,Gadois C,McCloskey E,et al. Protective effect of beta blockers in postmenopausal women:influence on fractures,bonedensity,micro and macro architecture [J]. Bone, 2007,40(5) : 1209-1216.
  • 7Bonnet N, Benhamou CL,Beaupied H,et al. Doping dose of salbutamol and exercise:deleterious effect on cancellous and cortical bones in adult rats [J]. Appl Physiol, 2007,102(4) : 1502-1509.
  • 8Bonnet N,Brunet IB,Arlettaz A,et al. Alteration of trabecular bone under chronic beta2 agonists treatment [J]. Med Sci Sports Exerc, 2005,37 (9) : 1493-1501.
  • 9Togari A,Arai M. Pharmacological topics of bone metabolism:the physiological function of the sympathetic nervous system in modulating bone resorption[J]. J Pharmacol Sci, 2008,106 (4) : 542-546.
  • 10Huang HH,Brennan TC,Muir MM,et al. Functional alphal-and beta2-adrenergic receptors in human osteoblasts [J]. J Cell Physiol, 2009,220( 1 ) : 267-275.

引证文献5

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部